… and transcriptome analysis reveals the chemotherapeutic effects of doxorubicin-loaded black phosphate nanosheets on abiraterone-resistant prostate cancer

H Xu, J Liu, X Li, J Li, X Lin, Z Li, T Dou, L Gao, R Li… - Bioorganic …, 2023 - Elsevier
… One of the reasons is a change in androgen receptor (AR) signaling, which leads to mCRPC.
Taxanes such as docetaxel are used as standard treatments for mCRPC [9]. However, only …

Androgen metabolism and response in prostate cancer anti-androgen therapy resistance

H Zhang, Y Zhou, Z Xing, RK Sah, J Hu… - International journal of …, 2022 - mdpi.com
… Excessive activation of androgen receptors (AR) by androgen … They are known as androgen
receptor signaling inhibitors (… and Erb-B2 receptor tyrosine kinase 2 (ErbB2) pathway also …

Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance

J Jian, X Wang, J Zhang, C Zhou, X Hou… - Frontiers in …, 2024 - frontiersin.org
… Currently, disorders in androgen receptor (AR)-related signaling are widely … ErbB2 stabilized
AR protein, and the expression of ERBB2 was increased in some abiraterone-resistant PCa …

Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer

EM Ledet, MB Lilly, G Sonpavde, E Lin… - The …, 2020 - academic.oup.com
… prognosis in prostate cancer (PCa). The goal was to characterize androgen receptor gene
(AR… and to further understand the somatic genetic heterogeneity of advanced prostate cancer. …

[HTML][HTML] Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: Opportunities to overcome a difficult problem

R Wahdan-Alaswad, B Liu, AD Thor - Cancer Drug Resistance, 2020 - ncbi.nlm.nih.gov
… nuclear receptors, particularly the androgen receptor. We discuss members of the HER
receptor … cues by estrogen-signaling, targeting of the androgen receptor is also feasible with the …

Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy

B Congregado Ruiz, I Rivero Belenchón… - Biomedicines, 2023 - mdpi.com
… In this setting, targeting the androgen receptor (AR) signaling axis, whose activation is …
Abiraterone-resistant xenograft models have increased ErbB2 activity. It has been demonstrated …

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

KJ Thompson, RA Leon-Ferre, JP Sinnwell… - … cancer, 2022 - academic.oup.com
… the human epidermal growth factor receptor 2 (HER2, ERBB2). … , gene signatures linked to
AR, ESR1 and ERBB2 signaling … has drawn comparisons with prostate cancer and therein the …

Pulmonary metastasis secondary to abirateroneresistant prostate cancer with homozygous deletions of BRCA2: first Japanese case

M Izawa, T Kosaka, K Nakamura, J Oba… - IJU Case …, 2021 - Wiley Online Library
prostate cancers acquire the capacity for androgen‐independent growth and become
resistant to androgen … strategy is needed for aggressive castration‐resistant prostate cancer. …

AR-dependent phosphorylation and phospho-proteome targets in prostate cancer

VB Venkadakrishnan, S Ben-Salem… - … -related cancer, 2020 - erc.bioscientifica.com
Prostate cancer (CaP) is the second leading cause of cancer-related deaths in Western men.
Because androgens drive CaP by activating the androgen receptor (AR), … with signaling

Circulating tumor cell gene expression and plasma AR gene copy number as biomarkers for castration-resistant prostate cancer patients treated with cabazitaxel

G Gurioli, V Conteduca, N Brighi, E Scarpi, U Basso… - BMC medicine, 2022 - Springer
… with plasma androgen receptor (AR) copy number (CN). … androgen-signaling-targeted
inhibitors, such as increased AR … EPCAM, EGFR, ERBB2: EPCAM expression is present on the …